Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.7800
+0.0100 (1.30%)
Jun 27, 2025, 4:00 PM - Market closed
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $3.39 million as of June 27, 2025. Its market cap has decreased by -25.70% in one year.
Market Cap
3.39M
Enterprise Value
-3.39M
1-Year Change
-25.70%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $3.39M, a decrease of -98.36%. That is a compound annual growth rate of -75.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 3.34M | -65.78% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 220.36B |